Luliconazole PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Luliconazole PCD pharma franchise company offering a portfolio of 6 Luliconazole formulations. We supply quality-assured, consistently manufactured Luliconazole products to franchise partners and distributors across India on a monopoly (district-wise) basis.

What is Luliconazole?

Luliconazole is a topical imidazole (azole) antifungal that inhibits fungal lanosterol 14-alpha-demethylase, blocking the synthesis of ergosterol needed for the fungal cell membrane and thereby killing dermatophytes. It is used to treat superficial fungal skin infections. Reference: PubChem.

Available Forms

Our Luliconazole range is available as Cream, Dusting Powder and Soap, allowing partners to serve diverse prescriptions from a single reliable supplier.

Therapeutic Applications of Luliconazole

Luliconazole is indicated for the topical treatment of tinea corporis (ringworm), tinea cruris (jock itch), tinea pedis (athlete’s foot) and other dermatophytoses. It is commonly prescribed by dermatologists and general physicians.

Why Luliconazole is a High-Potential Molecule for Distributors

Fungal skin infections are extremely common in India’s hot, humid climate and recur seasonally, sustaining strong demand for topical antifungals. Luliconazole’s once-daily dosing and short treatment course improve compliance and cure rates, and forms such as cream, dusting powder and medicated soap let distributors capture both treatment and preventive/hygiene purchases.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent pricing and dependable supply chain help distributors build a profitable long-term business.

References

1. PubChem - Luliconazole
2. DrugBank - Luliconazole
3. PubMed - Luliconazole research